Auro Laboratories Ltd

NSE: AUROLAB · BSE: 530233 · Pharmaceuticals & Biotechnology · 15 announcements

Auro Laboratories Ltd news stories on ALFA NewsRead the news →

Share price: ₹232.55
Market cap: ₹144.9 Cr
Revenue (annual): ₹32.61 Cr
Net profit (annual): ₹3.53 Cr
P/E (TTM): 30.9×Sector 47.3×
Promoter holding: 52.40%+0.22% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Regulatory Approval 2 Other Announcement 2 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Credit Rating 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

10 Aug 2026 19:03 IST BSE

Board Meeting Date

Auro Laboratories Board Meeting Date

Auro Laboratories Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

25 May 2026 20:38 IST BSE

Board Meeting Date

Auro Laboratories Board Meeting Date

Auro Laboratories scheduled a board meeting for May 29, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-announcement.

Read the filing ↗